Browse by topic
Subscribe to our news

team members | IVDR

Dr. Heike Moehlig-Zuttermeister Joins RQM+ as IVD Vice President Intelligence and Innovation

on 9 February 2022 | By RQM+ Subject Matter Experts
RQM+ is excited to announce the addition of Dr. Heike Moehlig-Zuttermeister as IVD Vice President Intelligence and Innovation. Heike joins us after nearly eight years at BSI, where she held leadership roles within the IVD team.
Read Now

In case you missed it: 2021 Expert Content from the RQM+ Knowledge Center

on 31 January 2022 | By RQM+ Subject Matter Experts
“RQM+ is always the first resource I think of when assistance is needed. In addition I cannot state how grateful I am for your organizations thought leadership and resources/content. It’s best in class!” In 2021, we launched the RQM+ Knowledge Center as your one-stop-shop to access a filterable library of content brought to you by our expert team's unrivaled collective knowledge.   Below is a recap of some of our content produced throughout 2021. You can always find each of these resources as well as all of the content we've produced so far in 2022 in our Knowledge Center. Be sure to subscribe to our blog to receive timely industry news, technical briefs, and expert content straight to your inbox. Please note: The content listed below was created prior to the announcement of the extension to the IVDR transition period. Check out the RQM+ Executive Video Briefing: IVDR New Transition Timelines for a more recent review of the revised IVDR timeline.
Read Now

MDR | IVDR | SSCP Requirements | Safety and Performance (SSP)

Overcoming Challenges and Streamlining Your SSCPs and SSPs

on 8 November 2021 | By RQM+ Subject Matter Experts
In case you missed it, the latest presentation in our webinar series covers the new requirements under EU MDR and IVDR: the Summary of Safety and Clinical Performance (SSCP) and Summary of Safety and Performance (SSP), respectively. It’s no surprise that manufacturers are finding it challenging to produce these reports because they are completely new to everybody. 
Read Now

team members | IVDR

Carlos Galamba Joins RQM+ as IVD Director

on 7 October 2021 | By RQM+ Subject Matter Experts
RQM+ is excited to announce the addition of Carlos Galamba as IVD Director after several years working for one of the largest Notified Bodies leading a global IVD team and assisting in the IVDR transition efforts.
Read Now

team members

Dr. Andrew Tarnaris Joins RQM+ as Medical Director

on 21 September 2021 | By RQM+ Subject Matter Experts
RQM+ is excited to announce the addition of Dr. Andrew Tarnaris as Medical Director. With a background as both a medical doctor and notified body clinical expert, he represents an excellent example of our unique combination of clinical and regulatory experience.
Read Now

MDR | Clinical Evaluation Report

RQM+ MDR Clinical Evaluation Roadmap: An Interview with Dr. Jai Kutty

on 9 September 2021 | By RQM+ Subject Matter Experts
The introduction of MDR caused a major transformation in the medical device industry. Manufacturers continue to grapple with all elements of compliance, but clinical evaluation presents unique challenges. RQM+ is committed to helping clients navigate these challenges with former notified body leaders who understand what reviewers are looking for when evaluating clinical evidence.
Read Now

EU MDR

RQM+ Case Study: Effective Managed Outsourcing for EU MDR

on 2 August 2021 | By RQM+ Subject Matter Experts
THE PROJECT A leading global company offering medical technology, services, and solutions engaged RQM+ to help four business units prepare for the EU Medical Device Regulation (MDR). Specifically, RQM+ is focused on assessing and remediating gaps in MDD technical files and building compliant MDR technical documentation files for submission.
Read Now

IVDR

[Webinar] Strategies for Overcoming the Biggest Challenges in Achieving IVDR Compliance

on 21 June 2021 | By RQM+ Subject Matter Experts
The latest addition to our webinar series covers the biggest challenges in IVDR compliance. With hundreds of MDR submissions under our belts and a number of clients who have already received findings from their IVDR applications, we have learned a lot about the regulation, the guidance that surrounds it, and what notified bodies expect to see.
Read Now

Design History File

How to Prepare a Design History File for FDA Inspection

on 1 June 2021 | By RQM+ Subject Matter Experts
Food and Drug Administration (FDA) inspections are stressful, especially if your documentation isn’t audit-ready. Creating and maintaining a compliant design history file (DHF) will help ensure that when the time comes, you’ll be ready for an FDA inspection that results in minimal findings.
Read Now

News

Leveraging PMCF Surveys for EU MDR Compliance - Part 2

on 15 December 2020 | By RQM+ Subject Matter Experts
When to use Post-Market Clinical Follow-up (PMCF) Surveys under the European Union's Medical Device Regulation.
Read Now

News

Lessons Learned: 2020 RAPS U.S. and Euro Convergence

on 23 November 2020 | By RQM+ Subject Matter Experts
RQM+ sponsored both RAPS U.S. and Euro Convergence conferences in 2020 and we also led and provided subject matter experts for two panel discussions. Our experts pulled together the highlights from both conferences and summarized them by category for our readers.
Read Now
1

We are passionate about your success. Tell us more about your regulatory and quality needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!